0
Skip to Content
BLOODPAC
BLOODPAC
About
Our Story
Our Team
Our Community
Annual Reports & Financials
Contact Us
Approach
How We Work
Reimbursement & Policy
Public Comments
Collaborative Studies
Data Commons
BLOODPAC Data Commons
BLOODPAC Discovery Portal
Recommended Preanalytical Data Elements
Data Model & Governance
Data Commons FAQs
Impact
Frameworks & Standards
BLOODPAC Publications
Member Publications
BLOODPAC Events
Resources
Insights
Videos
MEMBER LOGIN
BLOODPAC
BLOODPAC
About
Our Story
Our Team
Our Community
Annual Reports & Financials
Contact Us
Approach
How We Work
Reimbursement & Policy
Public Comments
Collaborative Studies
Data Commons
BLOODPAC Data Commons
BLOODPAC Discovery Portal
Recommended Preanalytical Data Elements
Data Model & Governance
Data Commons FAQs
Impact
Frameworks & Standards
BLOODPAC Publications
Member Publications
BLOODPAC Events
Resources
Insights
Videos
MEMBER LOGIN
Folder: About
Back
Our Story
Our Team
Our Community
Annual Reports & Financials
Contact Us
Folder: Approach
Back
How We Work
Reimbursement & Policy
Public Comments
Collaborative Studies
Folder: Data Commons
Back
BLOODPAC Data Commons
BLOODPAC Discovery Portal
Recommended Preanalytical Data Elements
Data Model & Governance
Data Commons FAQs
Folder: Impact
Back
Frameworks & Standards
BLOODPAC Publications
Member Publications
BLOODPAC Events
Folder: Resources
Back
Insights
Videos
MEMBER LOGIN
New Op-Ed in STAT News: Address liquid biopsy disparities today to ensure equity in outcomes tomorrow
News Guest User 8/26/24 News Guest User 8/26/24

New Op-Ed in STAT News: Address liquid biopsy disparities today to ensure equity in outcomes tomorrow

Read More
Thought Leaders in Liquid Biopsy: Dr. Howard Scher (Memorial Sloan Kettering Cancer Center)
Member Spotlight Guest User 3/21/23 Member Spotlight Guest User 3/21/23

Thought Leaders in Liquid Biopsy: Dr. Howard Scher (Memorial Sloan Kettering Cancer Center)

Read More
Thought Leaders in Liquid Biopsy: A Conversation with Dr. Anne-Marie Martin (Global Head of Experimental Medicine, GSK)
Member Spotlight Guest User 3/10/23 Member Spotlight Guest User 3/10/23

Thought Leaders in Liquid Biopsy: A Conversation with Dr. Anne-Marie Martin (Global Head of Experimental Medicine, GSK)

Read More
Thought Leaders in Liquid Biopsy: A Conversation with Dr. Phil Febbo (CMO, Illumina)
Member Spotlight Guest User 3/2/23 Member Spotlight Guest User 3/2/23

Thought Leaders in Liquid Biopsy: A Conversation with Dr. Phil Febbo (CMO, Illumina)

Read More
New Paper on Contrived Materials in Liquid Biopsy Validation from BLOODPAC
News Guest User 2/22/23 News Guest User 2/22/23

New Paper on Contrived Materials in Liquid Biopsy Validation from BLOODPAC

Read More
Breast Cancer Research Foundation & Prostate Cancer Foundation Commit to Supporting BLOODPAC
News Laura Tramontozzi 12/20/16 News Laura Tramontozzi 12/20/16

Breast Cancer Research Foundation & Prostate Cancer Foundation Commit to Supporting BLOODPAC

Read More

ABOUT

BLOODPAC is a consortium managed by the Center for Computational Science Research, Inc. (CCSR), which is an Illinois based 501 (c)(3) not-for-profit corporation. Our mandate is to accelerate the development and validation of liquid biopsy assays to improve the outcomes of patients with cancer. To do so we developed the BLOODPAC Data Commons that enables sharing of information between stakeholders in industry, academia, and regulatory agencies.